Corcept Therapeutics Inc. (CORT) is a publicly traded Healthcare sector company. As of May 21, 2026, CORT trades at $58.50 with a market cap of $5.92B and a P/E ratio of 58.52. CORT moved +1.58% today. Year to date, CORT is +68.98%; over the trailing twelve months it is -22.51%. Its 52-week range spans $28.66 to $117.33. Analyst consensus is strong buy with an average price target of $86.25. Rallies surfaces CORT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Corcept Therapeutics Inc. (CORT) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. CORT moved +1.58% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $58.50 |
| Market Cap | $5.92B |
| P/E Ratio | 58.52 |
| EPS | $1.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $117.33 |
| 52-Week Low | $28.66 |
| Volume | 992.91K |
| Avg Volume | 0 |
| Revenue (TTM) | $741.17M |
| Net Income | $106.11M |
| Gross Margin | 98.19% |
6 analysts cover CORT: 0 strong buy, 5 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $86.25.